Mirabaud & Cie Sa Novo Nordisk A S Transaction History
Mirabaud & Cie Sa
- $318 Million
- Q3 2025
A detailed history of Mirabaud & Cie Sa transactions in Novo Nordisk A S stock. As of the latest transaction made, Mirabaud & Cie Sa holds 10,000 shares of NVO stock, worth $484,600. This represents 0.17% of its overall portfolio holdings.
Number of Shares
10,000
Previous 7,500
33.33%
Holding current value
$484,600
Previous $517,000
7.16%
% of portfolio
0.17%
Previous 0.16%
Shares
3 transactions
Others Institutions Holding NVO
# of Institutions
1,698Shares Held
303MCall Options Held
27.9MPut Options Held
44.7M-
Capital International Investors Los Angeles, CA17.7MShares$858 Million0.17% of portfolio
-
Loomis Sayles & CO L P16.2MShares$783 Million1.1% of portfolio
-
Franklin Resources Inc San Mateo, CA14MShares$678 Million0.21% of portfolio
-
Bank Of America Corp Charlotte, NC13.4MShares$650 Million0.05% of portfolio
-
Morgan Stanley New York, NY12.4MShares$602 Million0.04% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $109B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...